Phage displayed antibodies to heat stable alkaline phosphatase: Framework region as a determinant of specificity

Journal of Biochemistry

Volumn 132, Issue 4, 2002, Pages 535-541

  Kala, Mrinalini ^a,c   Misra, Anjan ^a,b   Saini, Deepti ^a   Bajaj, Kiran ^a   Sinha, Subrata ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Antibody specificity; Framework region; Phage display; scFv

Indexed keywords

ALKALINE PHOSPHATASE; ENZYME ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; BOVINE SERUM ALBUMIN; IMMUNOGLOBULIN FRAGMENT; IMMUNOGLOBULIN HEAVY CHAIN; ISOENZYME; PEPTIDE LIBRARY; RECOMBINANT PROTEIN;

ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CROSS REACTION; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; IMMUNOTHERAPY; PHAGE DISPLAY; PROTEIN EXPRESSION; TUMOR CELL; AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; BIOTINYLATION; CELL CULTURE; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HEAT; HELA CELL; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGY; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS;

ALKALINE PHOSPHATASE; AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; BIOTINYLATION; CLONING, MOLECULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HEAT; HELA CELLS; HUMANS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; ISOENZYMES; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; RECOMBINANT PROTEINS; SERUM ALBUMIN, BOVINE; TUMOR CELLS, CULTURED;

EID: 0036775841     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jbchem.a003254     Document Type: Article

References (50)

1. Tokumitsu, S., Kohnoe, K., Takeya, M., and Takeuchi, T. (1979) Localization of alkaline phosphatase isoenzymes in human cancer cells in vitro. Acta Histochem. Cytochem. 12, 631
2. Badger, K.S. and Sussman, H.H. (1976) Structural evidence that human liver and placental alkaline phosphatase isoenzymes are coded by different genes. Proc. Natl. Acad. Sci. USA 73, 2201-2205
3. Kammer, G.M., Walter, E.I., and Medof, M.E. (1988) Association of cytoskeletal re-organization with capping of the complement decay-accelerating factor on T lymphocytes. J. Immunol. 141, 2924-2928
4. Tausk, F., Fey, M., and Gigli, I. (1989) Endocytosis and shedding of the decay accelerating factor on human polymorphonuclear cells. J. Immunol. 143, 3295-3302
5. Nathanson, L. and Fishman, W.H. (1971) New observations on the Regan isozymes of alkaline phosphtase in cancer patients. Cancer 27, 1388-1397
6. Holmgrem, P.A., Stigbrand, T., Damber, M.G., and von Schoultz B.A. (1978) Double antibody solid phase radioimmunoassay for placental alkaline phosphatase. Clin. Chem. Acta 83, 205-210
7. Fishman, W.H. and Stolbach, L.L. (1979) Placental alkaline phosphatase. Immunodiagnosis of Cancer (Herberman and Mc Intire, eds.) pp. 442, Marcel Dekker, New York
8. Sasaki, M. and Fishman, W.H. (1973) Ultrastructural studies on Regan and non-Regan isoenzymes of alkaline phosphatase in human ovarian cancer cells. Cancer Res. 33, 3008-3018
9. Usategui-Gomez, M., Yeager, F.M., and de Castro, A.F. (1973) A sensitive immunochemical method for the determination of the Regan isozyme in serum. Cancer Res. 33, 1574-1577
10. Cadeau, B.J., Blackstein, M.E., and Malkin, A. (1974) Increased incidence of placental-like alkaline phosphatase activity in breast and genitourinary cancer. Cancer Res. 34, 729-732
11. Szentirmay, Z., Sugar, J., and Kralovanszky, J. (1982) Early detection of human gastric cancer based on morphologic and enzymologic studies. Cancer Detect. Prev. 5, 185-194
12. Embleton, M.J. (1987) Drug-targeting by monoclonal antibodies. Br. J. Cancer 55, 227-231
13. Epenetos, A.A., Munro, A.J., Stewart, S., Rampling, R., Lambert, H.E., McKenzie, C.G., Soutter, P., Rahemtulla, A., Hooker, G., Sivolapenko, G.B., et al. (1987) Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabelled monoclonal antibodies. J. Clin. Oncol. 5, 1890-1899
14. Spitler, L.E., del Rio, M., Khentigan, A., Wedel, N.I., Brophy, N.A., Miller, L.L., Harkonen, W.S., Rosendorf, L.L., Lee, H.M., Mischak, R.P., et al. (1987) Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin. Cancer Res. 47, 1717-1723
15. Vitetta, E.S., Fulton, R.J., May, R.D., Till, M., and Uhr, J.W. (1987) Redesigning nature's poisons to create anti-tumor reagents. Science 238, 1098-1104
16. Takahashi, T., Yamaguchi, T., Kitamura, K., Suzuyama, H., Honda, M., Yokota, T., Kotanagi, H., Takahashi, M., and Hashimoto, Y. (1988) Clinical application of monoclonal antibodydrug conjugates for immunotargeting chemotherapy of colorectal carcinoma. Cancer 61, 881-888
17. Mach, J.P., Pelegrin, A., and Buchegger, F. (1991) Imaging and therapy with monoclonal antibodies in non-haematopoietic tumors. Curr. Opinion Immunol. 3, 685-693
18. Goding, J.W. (1980) Antibody production by hybridomas. J. Immunol. Methods 39, 285-308
19. Skerra, A. and Pluckthün, A. (1988) Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science 240, 1038-1041
20. Huse, W.D., Sastry, L., Iverson, S.A., Kang, A.S., Mees, M.A., Burton, D.R., Benkovic, S.J., and Lernerm, R.A. (1989) Generation of large combinatorial library of the immunoglobulin repertoire in phage lambda. Science 246, 1275-1281
21. McCafferty, J., Griffith, A.D., Winter, G., and Chiswell, D.J. (1990) Phage antibodies: Filamentous phage displaying antibody variable domains. Nature 348, 552-554
22. Barbas, C.F., Kang, A.S., Lerner, R.A., and Benkovic, S.J. (1991) Assembly of combinatorial antibody libraries on phage surfaces: The gene III site. Proc. Natl. Acad. Sci. USA 88, 7978-7982
23. Kang, A.S., Jones, T.M., and Burton, D.R. (1991) Antibody redesign by chain shuffling from random combinatorial immunoglobulin libraries. Proc. Natl. Acad. Sci. USA 88, 11120-11123
24. Posner, B., Lee, I., Itoh, T., Pyati, J., Graff, R., Thorton, G., LaPolla, R., and Benkovic, S.J. (1993) A revised strategy for cloning antibody gene fragments in bacteria. Gene 128, 111-117
25. Siegel, D.L. (2002) Recombinant monoclonal antibody technology. Transfus. Clin. Biol. 9, 15-22
26. Stadler, B.M. (1999) Antibody production without animals. Dev. Biol. Stand. 101, 45-48
27. Nissim, A., Hoogenboom, H.R., Tomlinson, I.M., Flynn, G., Midgley, C., Lane, D., and Winter, G. (1994) Antibody fragments from a 'single pot' phage dislpay library as immunochemical reagents. EMBO J. 13, 692-698
28. Calcutt, M.J., Komissarov, A.A., Marchbank, M.T., and Deutscher, S.L. (1996) Analysis of a nucleic-acid-binding antibody fragment. Construction and characterization of heavy-chain complementarity-determining region switch variants. Gene 168, 9-14
29. Chothia, C. and Lesk, A.M. (1987) Canonical structures for the hypervariable regions of immunoglobulins. J. Biol. Chem. 196, 901-917
30. Sheriff, S., Silverton, E.W., Padlan, E.A., Cohen, G.H., Smith-Gill, S.J., Finzel, B.C., and Davies, D.R. (1987) Three-dimensional structure of an antibody-antigen complex. Proc. Natl. Acad. Sci. USA 84, 8075-8079
31. Panka, D.J., Mudgett-Hunter, M., Parks, D.R., Peterson, L.L., Herzenberg, L.A., Haber, E., and Margolies, M.N. (1988) Variable region framework differences result in decreased or increased affinity of variant anti-digoxin antibodies. Proc. Natl. Acad. Sci. USA 85, 3080-3084
32. de Haard, H., Kazemier, B., van der Bent, A., Oudshoorn, P., Boender, P., Arends, J.W., and van Gemen, B. (1999) Vernier zone residue 4 of mouse subgroup II kappa light chains is a critical determinant for antigen recognition. Immunotechnology 4, 203-215
33. Khalifa, M.B., Weidenhaupt, M., Choulier, L., Chatellier, J., Rauffer-Bruyēre, N., Altschuh, D., and Vernet, T. (2000) Effects on interaction kinetics of mutation at the VH-VL interface of Fabs depend on the structural context. J. Mol. Recogni. 13, 127-139
34. Foote, J. and Winter, G. (1992) Antibody framework residues affecting the conformation of the hypervariable loops. J. Mol. Biol. 224, 487-499
35. H gene segments rearranged in vitro. J. Mol. Biol. 227, 381-388
36. Marks, J.D., Hoogenboom, H.R., Bonner, J.P., McCafferty, J., Griffiths, A.D., and Winter, G. (1991) By passing immunization: Human antibodies from V-gene libraries displayed on phage. J. Mol. Biol. 222, 581-597
37. Kala, M., Bajaj, K., and Sinha, S. (1997) Magnetic bead enzyme-linked immunosorbent Assay (ELISA) detects antigen-specific binding by phage-displayed scFv antibodies that are not detected with conventional ELISA. Anal. Biochem. 254, 263-266
38. Kala, M., Bajaj, K., and Sinha, S. (2001) Direct antigen capture by soluble scFv antibodies. Appl. Biochem. Biotechnol. 90, 11-22
39. Jemmerson, R., Klier, FG., and Fishman, W.H. (1985) Clustered distribution of human placental alkaline phosphatase on the surface of both placental and cancer cells. Electron microscopic observations using gold-labeled antibodies. J. Histochem. Cytochem. 33, 1227-1234
40. Al-Lazikani, B., Chothia, C., and Lesk, A.M. (1997) Standard conformations for the canonical structures of immunoglobulins. J. Mol. Biol. 273, 927-948
41. Chatellier, J., Van Regenmortel, M.H., Vernet, T., and Altschuh, D. (1996) Functional mapping of conserved residues located at the VL and VH domain interface of a Fab. J. Mol. Biol. 264, 1-6
42. Riechmann, L., Clark, M., Waldmann, H., and Winter, G. (1988) Reshaping human antibodies for therapy. Nature 332, 323-327
43. Verhoeyen, M., Milstein, C., and Winter, G. (1988) Reshaping human antibodies: Grafting an antilysozyme activity. Science 239, 1534-1536
44. Hakimi, J., Ha, V.C., Lin, P., Campbell, E., Gately, M.K., Tsudo, M., Payne, P.W., Waldmann, T.A., Grant, A.J., Tsien, W.H., et al. (1993) Humanized Mik beta 1, a humanized antibody to the IL-2 receptor beta-chain that acts synergistically with humanized anti-TAC. J. Immunol. 151, 1075-1085
45. Chothia, C., Lesk, A.M., Tramontano, A., Levitte, M., SmithGill, S.J., Air, G., Sheriff, S., Padlan, E.A., Davies, D., Tulip, W.R., Colman, P.M., Spinelli, S., Alzari, P.M., and Poljak, R.J. (1989) Conformations of immunoglobulin hypervariable regions. Nature 342, 877-883
46. Li, Y., Spellerberg, M.B., Stevenson, F.K., Capra, J.D., and Potter, K.N. (1996) The I binding specificity of human VH 4-34 (VH 4-21) encoded antibodies is determined by both VH framework region 1 and complementarity determining region 3. J. Mol Biol. 256, 577-589
47. Wu, T.T. and Kabat, E.A. (1992) Possible use of similar framework region amino acid sequences between human and mouse immunoglobulins for humanizing mouse antibodies. Mol. Immunol. 29, 1141-1146
48. Roguska, M.A., Pedersen, J.T., Keddy, C.A., Henry, A.H., Searle, S.J., Lambert, J.M., Goldmacher, V.S., Blattler, W.A., Rees, A.R., and Guild, B.C. (1994) Humanization of murine monoclonal antibodies through variable domain resurfacing. Proc. Natl. Acad. Sci. USA 91,969-973
49. Honegger, A. and Pluckthun, A. (2001) The influence of the buried glutamine or glutamate residue in position 6 on the structure of immunoglobulin variable domains. J. Mol. Biol. 309, 687-699
50. Jung, S., Spinelli, S., Schimmele, B., Honegger, A., Pugliese, L., Cambillau, C., and Pluckthun, A. (2001) The importance of framework residues H6, H7 and H10 in antibody heavy chains: Experimental evidence for a new structural subclassification of antibody V(H) domains. J. Mol. Biol. 309, 701-716